There’s a dangerous new type of activist investor betting on companies to fail — and that behavior could permanently change how firms raise money

Malaysia News News

There’s a dangerous new type of activist investor betting on companies to fail — and that behavior could permanently change how firms raise money
Malaysia Latest News,Malaysia Headlines
  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 37 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 18%
  • Publisher: 51%

Windstream's bankruptcy at the hands of Aurelius Capital is the latest example of how net-short debt activism can hurt companies.

, which was published in the Harvard Law School Forum on Corporate Governance and Financial Regulation.

As such, this subset of investors — known as"net-short debt activists" — are incentivized to hasten a corporation's default. Here's a quick rundown of how they operate:: Net-short debt activists identify a transaction that they can claim violates specific covenants in a company's debt documents.: Those activists build a position in the company's debt, while also amassing a larger short position.

The Wachtell Lipton study agrees with that last point: This type of behavior is becoming more commonplace. As a result, it's become a growing worry for many companies whose existing debt deals could contain troublesome covenants — ones that could be dug up and used against them.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

BusinessInsider /  🏆 729. in US

Malaysia Latest News, Malaysia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Activist Investor Claims Insurer’s CEO Uses Company Assets to Support LifestyleActivist Investor Claims Insurer’s CEO Uses Company Assets to Support LifestyleVoce Capital says Argo Group’s board is letting its chief executive misuse company assets on jet trips, designer office chairs and other expenses. The investor plans to launch a proxy fight against the company, which says its performance remains strong.
Read more »

Food-delivery company Doordash valued at $7.1 billion in new fund-raising roundFood-delivery company Doordash valued at $7.1 billion in new fund-raising roundThe company faces formidable competition from GrubHub, Postmates and Uber Eats, but CEO Tony Xu says the company will continue to focus on growth and delay profitability.
Read more »

Buffett's Suncor bet to revive investor interest in Canadian energyBuffett's Suncor bet to revive investor interest in Canadian energyBerkshire Hathaway Inc's re-investment in Suncor Energy Inc highlights the ...
Read more »

Zillow is betting big on flipping houses, and investors seem to like itZillow is betting big on flipping houses, and investors seem to like itZillow Group Inc., saying that “Uberized” consumers also want to instantly buy and sell homes with a click of a button on their phones, is making an even bigger bet on real estate buying, with projections that carry a lot of risk.
Read more »

Buffett encourages investors to bet on American economyBuffett encourages investors to bet on American economyBillionaire Warren Buffett releases his annual letter, says the company continues to perform well even though he hasn't found any major deals at attractive prices recently. He also wrote that investors should continue betting on the American economy.
Read more »

Cannabis producer Tilray is making a big bet on the world's largest hemp food companyCannabis producer Tilray is making a big bet on the world's largest hemp food companyThe Canadian marijuana-producer Tilray announced Wednesday that it is close to acquiring Manitoba Harvest, the world's largest hemp food company.
Read more »

Even the best stock-market investors fail when it’s time to sellEven the best stock-market investors fail when it’s time to sellEven the best stock-market investors fail when it’s time to sell (via MktwHulbert)
Read more »

Pharma giants are betting billions on gene therapies that could fundamentally change how we treat diseasesPharma giants are betting billions on gene therapies that could fundamentally change how we treat diseasesRecent deals like Roche's $4.8 billion bet on Spark and Novartis' $8.7 billion acquisition of AveXis show that big pharma is betting big on gene therapy.
Read more »



Render Time: 2025-02-27 11:11:33